D-0273-2022 Class III Terminated
FDA drug recall D-0273-2022 was initiated by Dr. Reddy's Laboratories, Inc. on Nov 12, 2021 and is designated Class III. Reason for recall: Failed dissolution specifications The recall status is terminated (terminated Jun 23, 2023).
Recall details
- Product Type
- Drugs
- Report Date
- Dec 15, 2021
- Initiation Date
- Nov 12, 2021
- Termination Date
- Jun 23, 2023
Product description
Allergy Relief D Fexofenadine HCl, 60 mg I Pseudoephedrine HCl, 120 mg, Extended Release Tablets, 30 Extended-Release Tablets USP, Distributed By CVS Pharmacy Inc., One CVS Drive, Woonsocket, RI 02985, Made in India, NDC 69842-249-30
Reason for recall
Failed dissolution specifications
Distribution pattern
USA Nationwide.
Code information
Lot #: AC2103329C, Exp 1/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0273-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026